Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 170

1.

Antipsychotic medication use in nursing homes: a proposed measure of quality.

Lucas JA, Chakravarty S, Bowblis JR, Gerhard T, Kalay E, Paek EK, Crystal S.

Int J Geriatr Psychiatry. 2014 Oct;29(10):1049-61. doi: 10.1002/gps.4098. Epub 2014 Mar 20.

PMID:
24648059
2.

Variation in use of antipsychotic medications in nursing homes in the United States: A systematic review.

Cioltan H, Alshehri S, Howe C, Lee J, Fain M, Eng H, Schachter K, Mohler J.

BMC Geriatr. 2017 Jan 26;17(1):32. doi: 10.1186/s12877-017-0428-1. Review.

4.

Off-label use of second-generation antipsychotic agents among elderly nursing home residents.

Kamble P, Sherer J, Chen H, Aparasu R.

Psychiatr Serv. 2010 Feb;61(2):130-6. doi: 10.1176/ps.2010.61.2.130.

PMID:
20123817
5.

Evaluation of nationally mandated drug use reviews to improve patient safety in nursing homes: a natural experiment.

Briesacher B, Limcangco R, Simoni-Wastila L, Doshi J, Gurwitz J.

J Am Geriatr Soc. 2005 Jun;53(6):991-6.

PMID:
15935022
6.

The quality of antipsychotic drug prescribing in nursing homes.

Briesacher BA, Limcangco MR, Simoni-Wastila L, Doshi JA, Levens SR, Shea DG, Stuart B.

Arch Intern Med. 2005 Jun 13;165(11):1280-5.

PMID:
15956008
7.

Use of antipsychotics among elderly nursing home residents with dementia in the US: an analysis of National Survey Data.

Kamble P, Chen H, Sherer JT, Aparasu RR.

Drugs Aging. 2009;26(6):483-92. doi: 10.2165/00002512-200926060-00005.

PMID:
19591523
8.

Unexplained variation across US nursing homes in antipsychotic prescribing rates.

Chen Y, Briesacher BA, Field TS, Tjia J, Lau DT, Gurwitz JH.

Arch Intern Med. 2010 Jan 11;170(1):89-95. doi: 10.1001/archinternmed.2009.469.

9.

Improving Nursing Home Compliance via Revised Antipsychotic Use Survey Tool.

Bach LL, Lazzaretto DL, Young CF, Lofholm PW.

Consult Pharm. 2017 Apr 1;32(4):228-238. doi: 10.4140/TCP.n.2017.228.

PMID:
28376988
10.

Assessment of antipsychotic prescribing in Belgian nursing homes.

Azermai M, Elseviers M, Petrovic M, van Bortel L, Stichele RV.

Int Psychogeriatr. 2011 Oct;23(8):1240-8. doi: 10.1017/S104161021100024X. Epub 2011 Mar 22.

PMID:
21418723
11.

An indicator of appropriate neuroleptic prescribing in nursing homes.

Oborne CA, Hooper R, Li KC, Swift CG, Jackson SH.

Age Ageing. 2002 Nov;31(6):435-9.

PMID:
12446288
12.

Rurality and nursing home quality: evidence from the 2004 National Nursing Home Survey.

Kang Y, Meng H, Miller NA.

Gerontologist. 2011 Dec;51(6):761-73. doi: 10.1093/geront/gnr065. Epub 2011 Jun 30.

PMID:
21719631
13.

Polypharmacy in nursing home residents in the United States: results of the 2004 National Nursing Home Survey.

Dwyer LL, Han B, Woodwell DA, Rechtsteiner EA.

Am J Geriatr Pharmacother. 2010 Feb;8(1):63-72. doi: 10.1016/j.amjopharm.2010.01.001.

PMID:
20226393
14.

Use of antipsychotics among older residents in VA nursing homes.

Gellad WF, Aspinall SL, Handler SM, Stone RA, Castle N, Semla TP, Good CB, Fine MJ, Dysken M, Hanlon JT.

Med Care. 2012 Nov;50(11):954-60. doi: 10.1097/MLR.0b013e31825fb21d.

15.

Variation in antipsychotic treatment choice across US nursing homes.

Huybrechts KF, Rothman KJ, Brookhart MA, Silliman RA, Crystal S, Gerhard T, Schneeweiss S.

J Clin Psychopharmacol. 2012 Feb;32(1):11-7. doi: 10.1097/JCP.0b013e31823f6f46.

PMID:
22198446
16.

Evaluation of neuroleptic drug use by nursing home elderly under proposed Medicare and Medicaid regulations.

Garrard J, Makris L, Dunham T, Heston LL, Cooper S, Ratner ER, Zelterman D, Kane RL.

JAMA. 1991 Jan 23-30;265(4):463-7.

PMID:
1670645
17.

Facility and county effects on racial differences in nursing home quality indicators.

Miller SC, Papandonatos G, Fennell M, Mor V.

Soc Sci Med. 2006 Dec;63(12):3046-59. Epub 2006 Sep 25.

PMID:
16997439
18.

Antipsychotic drug use among elderly nursing home residents in the United States.

Kamble P, Chen H, Sherer J, Aparasu RR.

Am J Geriatr Pharmacother. 2008 Oct;6(4):187-97. doi: 10.1016/j.amjopharm.2008.10.002.

PMID:
19028374
19.

Quality of psychopharmacological medication use in nursing home residents.

Simoni-Wastila L, Wei YJ, Luong M, Franey C, Huang TY, Rattinger GB, Zuckerman IH, Brandt N, Lucas JA.

Res Social Adm Pharm. 2014 May-Jun;10(3):494-507. doi: 10.1016/j.sapharm.2013.10.003. Epub 2013 Nov 15.

PMID:
24355380
20.

The impact of facility characteristics on the use of antipsychotic medications in nursing homes: a cross-sectional study.

Frankenthal D, Zandman-Goddard G, Ben-Muvhar Y, Porat-Katz BS.

Isr J Health Policy Res. 2016 Mar 16;5:12. doi: 10.1186/s13584-016-0070-y. eCollection 2016.

Supplemental Content

Support Center